Parkinson's Disease
Literature Review
Neurologic drug prices jump 50% in five years
Most of the increased cost was due to rising costs for neuroimmunology drugs, mainly for those used to treat multiple sclerosis (MS).
From the Journals
Neurologic disorders ubiquitous and rising in the U.S.
Most of the rise in disease burden could be attributed to population aging, while age-standardized figures showed stroke and dementias to be level...
Literature Review
Prostate drugs tied to lower risk for Parkinson’s disease
If confirmed by additional trials, glycolysis-enhancing drugs could be a new option to slow progression of Parkinson’s disease,
Literature Review
Ultrasound ablation for Parkinson’s disease: Benefit limited by adverse effects
“Longer-term and larger trials are needed to determine the role of focused ultrasound subthalamotomy in the management of Parkinson’s disease.”
News
Blood vessels in the eye may diagnose Parkinson’s disease
“We discovered that micro blood vessels decreased in both size and number in patients with Parkinson’s disease,”
Literature Review
Concussion linked to risk for dementia, Parkinson’s disease, and ADHD
A history of multiple concussions strengthened the association between concussion and subsequent mood and anxiety disorder, dementia, and...
Conference Coverage
Sublingual apomorphine alleviates off episodes in Parkinson’s disease
The sublingual film had more oral adverse effects than the injectable drug, but it may have advantages over subcutaneous apomorphine injections in...
From the Journals
A skin test for Parkinson’s disease diagnosis?
The preliminary study used a chemical assay to detect clumping of alpha-synuclein in autopsy skin samples taken from patients who had Parkinson’s...
Conference Coverage
Prodrug infusion beats oral Parkinson’s disease therapy for motor symptoms
The beneficial effects of the phosphate prodrugs were most noticeable in the early morning.
Conference Coverage
Telemedicine feasible and reliable in Parkinson’s trial
The findings have particular relevance to the ability to conduct a variety of clinical trials in the face of COVID-19 and the need to limit in-...
Literature Review
Blood biomarker may predict Parkinson’s disease progression
Neurofilament light chain levels are heightened in Parkinson’s disease and may aid diagnosis, but it is limited by low specificity.